期刊文献+

线粒体自噬在糖尿病肾病肾组织巨噬细胞表型转化中的作用 被引量:3

Mitophagy and macrophage M1/M2 phenotype transforming in diabetic nephropathy rats
下载PDF
导出
摘要 目的:探讨糖尿病肾病(DN)大鼠肾组织线粒体自噬特征与巨噬细胞M1/M2表型的相关性及在其分化中的作用。方法:建立DN大鼠模型分别于8周、12周、18周、24周末处死,病理染色观察肾脏病理改变,电镜观察肾组织线粒体形态数量和线粒体自噬。Western Blot检测肾组织巨噬细胞及线粒体自噬相关蛋白标志物表达。体外培养RAW264.7细胞,Western Blot和免疫荧光共聚焦比较自噬体生成抑制剂3-甲基腺嘌呤(3-MA)和自噬体生成激活剂雷帕霉素干预前后,巨噬细胞表型标志物和线粒体自噬相关指标的变化。结果:体内实验(1)从12周起,随着时间延长DN大鼠肾组织巨噬细胞浸润M1型增多,并且存在线粒体自噬障碍,表现为iNOS升高,LC3蛋白逐渐降低,p62升高;(2)相关性分析显示,iNOS与LC3成负相关(r=-0.617,P<0.05),而与p62成正相关(r=0.894,P<0.05);(3)电镜结果显示DN大鼠肾组织线粒体肿胀、线粒体嵴消失或降低,且存在线粒体自噬障碍。(4)免疫荧光共聚焦结果显示,DN大鼠肾组织线粒体标记蛋白VDAC和LC3较对照组均降低,共定位表达减少。体外实验(1)高糖干预后,Western Blot结果显示RAW264.7细胞肿瘤坏死因子α、iNOS随着时间延长逐渐升高,同时LC3、Beclin-1表达显著降低,p62明显升高,VDAC逐渐降低。(2)3-MA抑制自噬体生成能促进高糖诱导的巨噬细胞进一步向M1型巨噬细胞转化;(3)雷帕霉素激活自噬体生成能降低高糖诱导的M1型巨噬细胞活化。结论:线粒体自噬可能参与DN大鼠肾组织巨噬细胞M1/M2表型转化。 Objective: To investigate the effects of mitophage on macrophage polarization in rats with DN.Methodology: In vivo,DN model rats were established by intraperitoneal injection with streptozocin( STZ). Rats were sacrificed respectively at 8 w、12 w、18 w、24 w for histological and molecular analysis. In vitro,RAW264. 7 cells were cultured with 30 m M glucose with or without mitophage inhibitor( 3-MA) and activator( rapamycin) intervention. Mitophagy-related proteins expression of LC3,Beclin-1,p62,VDAC,i NOS( M1 marker) and MR( M2 marker) were detected by immunofluorescence and Western Blot. Results: Macrophage phenotype and mitophage had no obvious change in renal tissue of DN at 8 th weeks. However,macrophages were exhibited to M1 phenotype at 12 weeks after induction of DN and displayed a lower level of mitophagy. Additionally,i NOS expression was positive correlated with the p62 expression( r =0. 894,P〈0. 05),while negative correlated with LC3( r =-0. 617,P〈 0. 05). Electronic microscopic analysis showed mitochondria swelling,crista decrease and lysosome reduction in DN rats compared with NC rats. Moreover,RAW264. 7 macrophages switched to M1 phenotype under high glucose conditions. Meanwhile,mitophagy was downregulated in such high glucose induced M1 macrophages. Furthermore,macrophages expressed more i NOS and lower MR when impaired mitophagy by 3-MA. Rapamycin could significantly blocke high-glucose induced i NOS and enhance MR expression.Conclusion: Mitophage may participate in the regulation of M1/M2 macrophage phenotype in diabetic nephropathy.
作者 赵宇 郭银凤 朱小东 姜彧滕 刘玉秋 刘必成 张晓良 ZHAO Yu;GUO Yinfeng;Zhu Xiaodong;JIANG Yuteng;LIU Yuqiu;LIU Bicheng;ZHANG Xiaoliang(Institute of Nephrology , Zhong Da Hospital, School of Medicine, Southeast University, Nanjing 210009, China)
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2018年第2期106-112,共7页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家自然科学基金(81570612) 江苏省临床医学研究中心项目(BL2014080) 江苏省研究生科研与实践创新计划项目(KYLX16_0297 SJCX17_0056)
关键词 线粒体自噬 巨噬细胞 M1/M2表型 糖尿病肾病 mitophage macrophage M1/M2 phenotype diabetic nephropathy
  • 相关文献

参考文献3

二级参考文献28

  • 1Li JJ, Kwak SJ, Jung DS, et al. Podocyte biology in diabetic nephropathy[J]. Kidney Int Suppl, 2007, 106:S36-S42.
  • 2Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy[J]. Clin Sci (Lond), 2013, 124: 139-152.
  • 3Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint[J]. Kidney Int, 2008, 74: 22-36.
  • 4Wang G, Lai FM, Lai KB, et al. Urinary messenger RNA expression of podocyte- associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker[J]. Eur J Endoerinol,2008, 158: 317-322.
  • 5Cheng J, Zhang W, Zhang X, et al. Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis [J]. Clin J Am Soc Nephrol, 2012, 7: 391-400.
  • 6Deb DK, Sun T, Wong KE, et al. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes[J]. Kidney Int, 2010, 77: 1000-1009.
  • 7He W, Kang YS, Dai C, et al. Blockade of Wnt/beta- catenin signaling by paricalcitol ameliorates proteinuria and kidney injury[J]. J Am Soc Nephrol, 2011, 22: 90-103.
  • 8Deb DK, Chen Y, Zhang Z, et al. 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF- {kappa}B pathway[J]. Am J Physiol Renal Physiol, 2009, 296: F1212-F1218.
  • 9Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair[J], J Clin Invest, 2008, 118: 3522-3530.
  • 10Eardley KS, Zehnder D, Quinkler M, et al. The relationship between albuminuria, MCP - 1/CCL2, and interstitial macrophages in chronic kidney disease[J]. Kidney Int, 2006, 69: 1189-1197.

共引文献215

同被引文献39

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部